Form 8-K - Current report:
SEC Accession No. 0001193125-22-283649
Filing Date
2022-11-14
Accepted
2022-11-14 07:06:10
Documents
42
Period of Report
2022-11-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d411392d8k.htm   iXBRL 8-K 24554
2 EX-99.1 d411392dex991.htm EX-99.1 35942
3 EX-99.2 d411392dex992.htm EX-99.2 21441
7 GRAPHIC g411392ex99_2p10g1.jpg GRAPHIC 178020
8 GRAPHIC g411392ex99_2p11g1.jpg GRAPHIC 230515
9 GRAPHIC g411392ex99_2p12g1.jpg GRAPHIC 185545
10 GRAPHIC g411392ex99_2p13g1.jpg GRAPHIC 180864
11 GRAPHIC g411392ex99_2p14g1.jpg GRAPHIC 218894
12 GRAPHIC g411392ex99_2p15g1.jpg GRAPHIC 174758
13 GRAPHIC g411392ex99_2p16g1.jpg GRAPHIC 214408
14 GRAPHIC g411392ex99_2p17g1.jpg GRAPHIC 170664
15 GRAPHIC g411392ex99_2p18g1.jpg GRAPHIC 163827
16 GRAPHIC g411392ex99_2p19g1.jpg GRAPHIC 206828
17 GRAPHIC g411392ex99_2p1g1.jpg GRAPHIC 182501
18 GRAPHIC g411392ex99_2p20g1.jpg GRAPHIC 162754
19 GRAPHIC g411392ex99_2p21g1.jpg GRAPHIC 172138
20 GRAPHIC g411392ex99_2p22g1.jpg GRAPHIC 177803
21 GRAPHIC g411392ex99_2p23g1.jpg GRAPHIC 227505
22 GRAPHIC g411392ex99_2p24g1.jpg GRAPHIC 165162
23 GRAPHIC g411392ex99_2p25g1.jpg GRAPHIC 249867
24 GRAPHIC g411392ex99_2p26g1.jpg GRAPHIC 174639
25 GRAPHIC g411392ex99_2p27g1.jpg GRAPHIC 187582
26 GRAPHIC g411392ex99_2p2g1.jpg GRAPHIC 315139
27 GRAPHIC g411392ex99_2p3g1.jpg GRAPHIC 106966
28 GRAPHIC g411392ex99_2p4g1.jpg GRAPHIC 206381
29 GRAPHIC g411392ex99_2p5g1.jpg GRAPHIC 176143
30 GRAPHIC g411392ex99_2p6g1.jpg GRAPHIC 164880
31 GRAPHIC g411392ex99_2p7g1.jpg GRAPHIC 212428
32 GRAPHIC g411392ex99_2p8g1.jpg GRAPHIC 175938
33 GRAPHIC g411392ex99_2p9g1.jpg GRAPHIC 269389
34 GRAPHIC g411392new.jpg GRAPHIC 11548
  Complete submission text file 0001193125-22-283649.txt   7468375

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA tcrt-20221114.xsd EX-101.SCH 2846
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE tcrt-20221114_lab.xml EX-101.LAB 17237
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tcrt-20221114_pre.xml EX-101.PRE 10806
36 EXTRACTED XBRL INSTANCE DOCUMENT d411392d8k_htm.xml XML 3229
Mailing Address 8030 EL RIO STREET HOUSTON TX 77054
Business Address 8030 EL RIO STREET HOUSTON TX 77054 (346) 355-4099
Alaunos Therapeutics, Inc. (Filer) CIK: 0001107421 (see all company filings)

EIN.: 841475642 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33038 | Film No.: 221380113
SIC: 2834 Pharmaceutical Preparations